STCBIO

Oops! It appears that you have disabled your Javascript. In order for you to see this page as it is meant to appear, we ask that you please re-enable your Javascript!

July 31, 2020NewsBy stcbio

‘induced Pluripotent Stem Cell’ without Side Effects, the Hope to Overcome Incurable Diseases

[Dong-a] 2020.07.28

nEPS is a pluripotent stem cell which does not carry tumor or cancer occurrence, unlike other iPS we have in the market. STRI has already started making all the organs and tissues of the human being and is working on finding ways to treat incurable diseases, such as Parkinson’s disease or inhibiting the growth of liver cancer in mice.

“With the changes in civilization and culture in these fast-changing times, the new era of IT and BT(biotechnology) has already arrived. We will do our best to overcome incurable diseases of the human being with a humble mindset.” Kye-ho Lee, Chairman of STRI

Read our latest press release (Korean): https://lnkd.in/gAWXQp9

BACK

STRI PERFECTS STEM-CELL PLURIPOTENCY TO ENABLE 3D PRINTING OF HUMAN ORGANS
April 17, 2020

460 patents regarding nEPS are registered in 147 countries.
March 19, 2020

STRI registered a patent for liver cell differentiation using the world’s first pluripotent stem cells without side effects (nEPS) at EU
March 11, 2020

STRI achieved a patent for ‘liver cell differentiation using newly Elicited Pluripotent Stem Cells without side effects using natural compounds(nEPS)’ at EU
March 11, 2020

bBHC achieved a patent for ‘liver cell differentiation using newly Elicited Pluripotent Stem Cells without side effects by natural compounds(nEPS)’ in the EU followed by Korea, America, and Australia.
March 11, 2020

bBHC introduced Cell 97.7 and Celgen branded products at International Beauty Expo 2019
March 11, 2020